Evidence map›Paper›PMID 24377039›Full record

ArticleReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2012

Primary squamous cell carcinoma of the breast: A rare case report.

Stefania Carbone, Rosabel Lobo Alvarez, Annalisa Lamacchia, Asuncion Almenar Gil, Raquel Martin Hernandez, Jose Luis Lopez Guerra, Hugo Marsiglia

Abstract read
In one paragraph

Article in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Squamous cell carcinoma of the breast: About a case.International journal of surgery case reports · 2022
    Article
  4. Article
  5. Article
  6. Rare breast tumors: Review of the literature.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stefania CarboneDepartment of Radiation Oncology, Instituto Madrileño de Oncologia/Grupo IMO, Madrid, Spain.
Rosabel Lobo AlvarezDepartment of Radiation Oncology, Instituto Oncologico de Castilla La Mancha/Grupo IMO, Toledo, Spain.
Annalisa LamacchiaDepartment of Radiation Oncology, Instituto Madrileño de Oncologia/Grupo IMO, Madrid, Spain ; Department of Radiation Oncology, University of Bari, Bari, Italy.
Asuncion Almenar GilDepartment of Radiology, Hospital Virgen de la Salud, Toledo, Spain.
Raquel Martin HernandezDepartment of Pathology, Hospital Virgen de la Salud, Toledo, Spain.
Jose Luis Lopez GuerraDepartment of Radiation Oncology, Instituto Madrileño de Oncologia/Grupo IMO, Madrid, Spain.
Hugo MarsigliaDepartment of Radiation Oncology, Instituto Madrileño de Oncologia/Grupo IMO, Madrid, Spain ; Department of Radiation Oncology, Institut de cancérologie Gustave Roussy, Villejuif, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSquamous cells are normally not found inside the breast. Therefore, a primary squamous cell carcinoma of the breast is an exceptional phenomenon and the management of this type of disease is still debated.

aimClinical outcome assessment of a patient with squamous cell carcinoma of the breast. MATERIALS AND

methodsWe report a case of primary squamous cell carcinoma of the breast (T1cN0M0) in a 51-years-old woman who underwent breast conserving surgery plus adjuvant chemotherapy and radiation therapy (RT).

resultsWith a follow up of 43 months, the patient is alive with no evidence of local or distant recurrence. The patient had Grade 2 acute skin toxicity. No late skin or respiratory toxicity was observed.

conclusionsPure primary squamous cell carcinoma of the breast is a rare and aggressive disease, often treatment-refractory. Our case shows that the addition of RT after breast conserving surgery, allows to achieve a high local control without adding severe toxicity. A multidisciplinary approach seems to be the optimal management for early stages in this rare disease.

Indexed as

Breast cancerOutcomeSquamous cell carcinoma

Identifiers

PMID24377039
PMCPMC3863314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.